Legis Daily

Adding Epidemic Diseases to the FDA Priority Review Voucher Program Act

USA116th CongressHR-4553| House 
| Updated: 9/30/2019
Brendan F. Boyle

Brendan F. Boyle

Democratic Representative

Pennsylvania

Cosponsors (4)
Roger Marshall (Republican)Marc A. Veasey (Democratic)Jeff Fortenberry (Republican)Bryan Steil (Republican)

Health Subcommittee, Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Adding Epidemic Diseases to the FDA Priority Review Voucher Program Act This bill expands the priority-review voucher program for tropical diseases to include Middle East respiratory syndrome, Nipah virus, and Rift Valley fever. A voucher entitles the holder to have a future new drug or biological product application acted upon by the Food and Drug Administration within six months.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Sep 27, 2019
Introduced in House
Sep 27, 2019
Referred to the House Committee on Energy and Commerce.
Sep 30, 2019
Referred to the Subcommittee on Health.
  • September 27, 2019
    Introduced in House
  • September 27, 2019
    Referred to the House Committee on Energy and Commerce.
  • September 30, 2019
    Referred to the Subcommittee on Health.

Health

Cardiovascular and respiratory healthDrug safety, medical device, and laboratory regulationDrug therapyInfectious and parasitic diseases

Adding Epidemic Diseases to the FDA Priority Review Voucher Program Act

USA116th CongressHR-4553| House 
| Updated: 9/30/2019
Adding Epidemic Diseases to the FDA Priority Review Voucher Program Act This bill expands the priority-review voucher program for tropical diseases to include Middle East respiratory syndrome, Nipah virus, and Rift Valley fever. A voucher entitles the holder to have a future new drug or biological product application acted upon by the Food and Drug Administration within six months.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Sep 27, 2019
Introduced in House
Sep 27, 2019
Referred to the House Committee on Energy and Commerce.
Sep 30, 2019
Referred to the Subcommittee on Health.
  • September 27, 2019
    Introduced in House
  • September 27, 2019
    Referred to the House Committee on Energy and Commerce.
  • September 30, 2019
    Referred to the Subcommittee on Health.
Brendan F. Boyle

Brendan F. Boyle

Democratic Representative

Pennsylvania

Cosponsors (4)
Roger Marshall (Republican)Marc A. Veasey (Democratic)Jeff Fortenberry (Republican)Bryan Steil (Republican)

Health Subcommittee, Energy and Commerce Committee

Health

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Cardiovascular and respiratory healthDrug safety, medical device, and laboratory regulationDrug therapyInfectious and parasitic diseases